Pharmaceutical firm Eli Lilly & Co. has started an early-stage trial to test a treatment for the coronavirus in the world’s first study of an antibody treatment against the virus, the company announced Monday.
Pharmaceutical firm Eli Lilly & Co. has started an early-stage trial to test a treatment for the coronavirus in the world’s first study of an antibody treatment against the virus, the company announced Monday.
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
We'll send a verification code to %EMAIL%.
Get the best of The Washington Informer directly in your email inbox.
Sending to: